A prospective study of fibrinogen and risk of myocardial infarction in the physicians’ health study
- 26 March 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 33 (5) , 1347-1352
- https://doi.org/10.1016/s0735-1097(99)00007-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Effect of plasma fibrinogen concentration on the inhibition of platelet aggregation after ticlopidine compared with aspirin.Stroke, 1994
- The role of fibrinogen as a cardiovascular risk factorAtherosclerosis, 1993
- Plasma fibrinogen and coronary risk factors: The Scottish heart health studyJournal of Clinical Epidemiology, 1990
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patientsAtherosclerosis, 1988
- Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell Collaborative Surveys.Journal of Clinical Pathology, 1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Epidemiological characteristics of platelet aggregability.BMJ, 1985
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957